Press release
Feb 2, 2018

First Half FY2017 Corporate Update to Shareholders Now Available


Tokyo, Japan and London, United Kingdom – 2 February 2018: Sosei Group Corporation (“Sosei” or the “Company”; TSE Mothers Index: 4565), the world leader in GPCR medicine design and development, is pleased to announce that the first half FY2017 Corporate Update to Shareholders (Kabunushi Tsushin) is now available.   


 DOWNLOAD PDF